Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1175 of 1,261
  1. US 6596705

    Inhibition of L-selectin and P-selection mediated binding using heparin

    The Regents of the University of California Β· Granted Jul 22, 2003 Β· Expires Jul 17, 2023

    expired
  2. US 6596690

    Vasostatin as marrow protectant

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 22, 2003 Β· Expires Jul 17, 2023

    expired
  3. US 6596321

    Pharmaceutical composition for treating angiocardiopathy and the method of producing thereof

    CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Jul 22, 2003 Β· Expires Jul 17, 2023

    expired
  4. US 6596544

    Functional assay of high-density lipoprotein

    The Regents of the University of California Β· Granted Jul 22, 2003 Β· Expires Jul 17, 2023

    expired
  5. US 6596269

    Methods of treating chronic pain

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 22, 2003 Β· Expires Jul 17, 2023

    expired
  6. US 6593493

    RXR modulators with improved pharmacologic profile

    Ligand Pharmaceuticals Incorporated Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  7. US 6593459

    Synthetic glycosulfopeptides and methods of synthesis thereof

    The Board of Regents of the University of Oklahoma Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  8. US 6593456

    Tumor necrosis factor receptor releasing enzyme

    The Regents of the University of California Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  9. US 6593307

    Cyclic-ADP-ribose analogs

    Regents of the University of Minnesota Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  10. US 6593359

    Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

    Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  11. US 6593306

    Methods for modulation and inhibition of telomerase

    The Board of Regents of the University of Texas System Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  12. US 6593394

    Bioactive and osteoporotic bone cement

    Prosperous Kingdom Limited Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  13. US 6593144

    Magnetic resonance imaging using hyperpolarized noble gases

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  14. US 6593125

    Human kinases and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  15. US 6592872

    Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  16. US 6593119

    Core 2 &bgr;-1,6-N-acetylglycosaminyltransferase gene

    GlycoDesign Holdings Ltd. Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  17. US 6593308

    Targeted drug delivery with a hyaluronan ligand

    The Regents of the University of California Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  18. US 6592869

    Vaccine composition and method of using the same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  19. US 6593357

    Pyrazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated Β· Granted Jul 15, 2003 Β· Expires Jul 10, 2023

    expired
  20. HK 1004528

    Dentifrice compositions

    BEECHAM GROUP PLC [GB] Β· Granted Jul 10, 2003 Β· Expires Jul 5, 2023

    expired
  21. US 6589531

    Recombinant yellow fever virus and method of use thereof

    The Regents of the University of California Β· Granted Jul 8, 2003 Β· Expires Jul 3, 2023

    expired
  22. US 6590140

    Metal-regulated transporters and uses therefor

    Regents of the University of Minnesota Β· Granted Jul 8, 2003 Β· Expires Jul 3, 2023

    expired
  23. US 6589560

    Stable glassy state powder formulations

    Nektar Therapeutics Β· Granted Jul 8, 2003 Β· Expires Jul 3, 2023

    expired
  24. US 6589547

    Sustained-release preparation for AII antagonist, production and use thereof

    Takeda Chemical Industries Ltd. Β· Granted Jul 8, 2003 Β· Expires Jul 3, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.